Stay updated on Tirzepatide in CKD and Obesity Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in CKD and Obesity Clinical Trial page.

Latest updates to the Tirzepatide in CKD and Obesity Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting certain services and products, as well as a specific date. Additionally, a new date has been added.SummaryDifference6%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check49 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check56 days agoChange DetectedA new addition was made on January 22, 2025, while a deletion occurred on December 27, 2024.SummaryDifference1.0%
- Check63 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check70 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
Stay in the know with updates to Tirzepatide in CKD and Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in CKD and Obesity Clinical Trial page.